The rising demand for products and services related to genetic testing and greater awareness among people for products and services propels the growth of the global genotyping market. It is a process of finding variations in the genetic make-up or genotype of a person through analyzing the individual’s DNA sequence and compare it with another individual’s sequence or reference sequence by utilizing biological assays. It shows the alleles a person has inherited from his parents. Genotyping is performed through different methods based on the resource available and variants of interest. Genotyping has its application on a wide range of individuals that involves microorganisms. For instance, bacteria and viruses can be genotyped.
To Request a Sample of our Report on Global Genotyping Market: https://www.omrglobal.com/request-sample/genotyping-market
The major factors affecting the genotyping market include advancements in technology and an increase in the prevalence of diseases such as diabetes, cancer, Alzheimer, asthma, and cardiovascular diseases. Genotyping assists by detecting the origin of outbreaks thus support in controlling of spreading of pathogens. This domain is known as forensic microbiology or molecular epidemiology. There are various methods of genotyping such as random amplified polymorphic detection (RAPD) of genomic DNA, fragment length polymorphism identification (RFLPI), polymerase chain reaction (PCR), amplified fragment length polymorphism detection (AFLPD), DNA sequencing, allele-specific oligonucleotide (ASO) probes, and hybridization to DNA microarrays or beads. The important application of genotyping includes the research of genes and gene variants connected with disease.
Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising usage of SNPs in biotechnology and life sciences are drivers of the genotyping market.
North America is expected to have a significant market size in the global genotyping market. The increasing need for personalized medicines, reducing costs of DNA sequencing, rising cases of genetic disorders, technological advancements are the factors giving rise to genotyping in the North American market. Canada is the second country after North America in market domination. The major players in the Genotyping market include Agilent Technologies Inc., Douglas Scientific LLC, Luminex Corp., Bio-Rad Laboratories Inc., Thermo Fischer Scientific Inc.
Asia-Pacific is predicted to grow as there are factors such as large population base, increasing the health awareness of genetic disorders, rising healthcare expenditure, and growing investments for research activities by academic & research institutes and biopharmaceutical companies. The emerging economies such as India and China are growing in this market due to the enhanced adoption and information about personalized medicine that will drive the demand for genotyping assay products and services in the Asia-Pacific.
(Get 15% Discount on Buying this Report)
A full Report of Global Genotyping Market is Available at: https://www.omrglobal.com/industry-reports/genotyping-market
Genotyping Market- Segmentation
By Products
• Reagents & Kits
• Instruments
By Technology
• Mass Spectrometry
• Microarray
• Sequencing
• Polymerase Chain Reaction
• Electrophoresis
• Others
By Application
• Drug Discovery
• Personalized Medicine
• Diagnostic Research
• Pharma Genomics
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
